Stroke assessment: Morphometric infarct size versus neurologic deficit

Journal of Neuroscience Methods

Volumn 83, Issue 2, 1998, Pages 151-157

  De Courten Myers, Gabrielle M ^a   Kleinholz, Marla ^b   Wagner, Kenneth R ^a,b   Myers, Ronald E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cerebral ischemia, focal; Cost and cost analysis; Middle cerebral artery occlusion; Neurologic deficits; Stroke assessment

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; CAT; CONTROLLED STUDY; FEMALE; HEMIPARESIS; HISTOPATHOLOGY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; STROKE;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; BLOOD GLUCOSE; BRAIN ISCHEMIA; CATS; CEREBRAL INFARCTION; CEREBROVASCULAR DISORDERS; COSTS AND COST ANALYSIS; FEMALE; HYPERGLYCEMIA; MALE; NEUROLOGIC EXAMINATION; PROGNOSIS;

EID: 0032169273     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(98)00073-9     Document Type: Article

References (23)

1. Auer R.N., Murray L., Jensen M.L., Whishaw I.Q. Neurobehavioral deficit due to ischemic brain damage limited to half of the CA 1 sector of the hippocampus. J Neurosci. 9(5):1989;1641-1647.
2. Awad I., Modic M., Little J.R., Furlan A.J., Weinstein M. Focal parenchymal lesion in transient ischemic attacks: Correlation of computed tomography and magnetic resonance imaging. Stroke. 17:1986;399-403.
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
4. Berguer R., Sieggreen M.Y., Lazo A., Hodakowski G.T. The silent brain infarct in carotid surgery. J Vasc Surg. 3:1986;442-447.
5. Brott T. The NIH Stroke Scale and the FIM in stroke rehabilitation. Letter to the editor. Stroke. 23:1992;919.
6. Brott T., Adams H.P. Jr., Olinger C.P., Marler J.R., Barsan W.G., Biller J., Spilker J., Holleran R., Eberle R., Hertzberg V., Rorick M., Moomaw C.J., Walker M. Measurements of acute cerebral infarction: A clinical examination scale. Stroke. 20:1989;864-870.
7. Brott T., Marler J.R., Olinger C.P., Adams H.P. Jr., Tomsick T., Barsan W.G., Biller J., Eberle R., Hertzberg V., Walker M. Measurement of acute cerebral infarction: Lesion size by computed tomography. Stroke. 20:1989;871-875.
8. de Courten-Myers G.M., Myers R.E. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume. Letter to the editor. Stroke. 25(5):1994;1082-1083.
9. de Courten-Myers G.M., Kleinholz M., Wagner K.R., Myers R.E. Determiners of fatal reperfusion brain oedema. Acta Neurochir. 51(Suppl):1990;226-229.
10. de Courten-Myers G.M., Kleinholz M., Wagner K.R., Myers R.E. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med. 21:1992;120-126.
11. de Courten-Myers G.M., Kleinholz M., Wagner K.R., Myers R.E. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion. J Cereb Blood Flow Metab. 14:1994;227-236.
12. Kawamata T., Alexis N.E., Dietrich W.D., Finkelstein S.P. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J Cereb Blood Flow Metab. 16(4):1996;542-547.
13. Lyden P.D., Zweifler R., Mahdavi Z., Lonzo L. A rapid, reliable and valid method for measuring infarct and brain compartment volumes from computed tomographic scans. Stroke. 25(12):1994;2421-2428.
14. Mohr T.P., Foulkes M.A., Polis A.T., Hier D.B., Kase C.S., Price T.R., Tatemichi T.K., Wolf P.A. Infarct topography and hemiparesis profiles with cerebral convexity infarction: the Stroke Data Bank. J Neurol Neurosurg Psychiatry. 56(4):1993;344-351.
15. Noseworthy J.H. Clinical scoring methods for multiple sclerosis [Review]. Ann Neurol. 36(Suppl):1994;S80-S85.
16. Persson L., Hardemark H.G., Bolander H.G., Hillered L., Olsson Y. Neurologic and neuropathologic outcome after middle cerebral artery occlusion in rats. Stroke. 20:1989;641-645.
17. Pullicino P., Snyder W., Granger C. The NIH stroke scale and the FIM in stroke rehabilitation. Stroke. 23:1992;919.
18. Rod M.R., Whishaw I.Q., Auer R.N. The relationship of structural ischemic brain damage to neurodeficit: The effect of postischemic MK-801. Can J Psychiatry. 44:1990;196-209.
19. Spetzler R.F., Martin N.A. A proposed grading system for arteriovenous malformations. J Neurosurg. 65:1986;476-483.
20. Valtysson J., Hillered L., Andine P., Hajbeg H., Persson L. Neuropathological endpoints in experimental stroke pharmacotherapy; the importance of both early and late evaluation. Acta Neurochir. 129(1-2):1994;58-63.
21. Wahl F., Allix M., Plotkine M., Boulu R.G. Neurological and behavioral outcome of focal cerebral ischemia in rats. Stroke. 23:1992;267-272.
22. Weber E., Allegrini P.R., Sauer D. Assessment of infarct volume in the mouse brain: Correlation of magnetic resonance imaging with morphometry. In Vivo. 7(4):1993;335-338.
23. Yamamoto M., Tamura A., Takaaki K., Shimizu M., Sano K. Effects of a new thyrotropin-releasing hormone derivate on behavioral changes after focal cerebral ischemia in rats. Stroke. 20:1989;362-366.